FIA
KIN

FNY Investment Advisers’s Kindred Biosciences, Inc. KIN Stock Holding History

FNY Investment Advisers’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed – – 1038
2021
Q2 		$0 Buy
+100
New +$582 ﹤0.01% 1062

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

FNY Investment Advisers's KIN Position: Q3 2021 in Review

FNY Investment Advisers sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 100 shares.

FNY Investment Advisers first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • FNY Investment Advisers reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 100 Kindred Biosciences, Inc. shares in Q3 2021.
  • FNY Investment Advisers first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • FNY Investment Advisers's Kindred Biosciences, Inc. position peaked at $0 in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on FNY Investment Advisers's 13F filing for Q3 2021, filed 13 Oct 2021.